Pediatric Psychopharmacology for Primary Care 3rd edition by Mark A Riddle – Ebook PDF Instant Download/DeliveryISBN: 1610025474, 9781610025478
Full download Pediatric Psychopharmacology for Primary Care 3rd edition after payment.
Product details:
ISBN-10 : 1610025474
ISBN-13 : 9781610025478
Author : Mark A Riddle
Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents. It includes digital tools offering instant access to additional information on psychotropic medications. TOPICS INCLUDE Conceptual framework for prescribing psychotropics Newly approved medications, changes in regulations and guidelines, and updates in the professional literature are included in this new edition Medications for specific diagnoses—ADHD, anxiety, and depression Food and Drug Administration approved antipsychotics and mood stabilizers and all other medications What to do when treatment is unsuccessful
Pediatric Psychopharmacology for Primary Care 3rd Table of contents:
Part 1: Before Prescribing
Chapter 1: Getting Started
Guiding Psychopharmacology Principles
Additional Guiding Principles
Organization and Overview
Selected Changes and Updates in Third Edition
Chapter 2: Conceptual Framework for Prescribing Psychotropic Medications
Rationale for the Conceptual Framework
Group 1 Medications for Attention-Deficit/Hyperactivity Disorder, Anxiety, and Depression
Group 2 Medications
Group 3 Medications
References
Chapter 3: Making a Diagnosis
Overview
Diagnosis of Common Disorders: ADHD, Anxiety Disorders, and Depression
Diagnosis of Common Comorbidities of ADHD, Anxiety Disorders, and Depression
Recognizing Other Psychiatric Disorders
Determine if Medication Is Indicated
Recognize Need for Referral
References
Chapter 4: Laying the Groundwork
Formulation
Feedback
Nonmedication Interventions
Informed Consent
Specific Consent Issues
Off-label Prescribing
US Food and Drug Administration Boxed Warnings
Triage for Psychiatric and Social Emergencies
Important Considerations for Safe and Effective Prescribing
References
Part 2: Group 1 Medications for Specific Diagnoses: Attention-Deficit/Hyperactivity Disorder, Anxiet
Chapter 5: Group 1 Medications for Attention-Deficit/Hyperactivity Disorder
General Guidance
Methylphenidate
Amphetamine
Guanfacine
Clonidine
Atomoxetine
Viloxazine
Summary
References
Chapter 6: Group 1 Medications for Anxiety and Depression
General Guidance
Group 1 Selective Serotonin Reuptake Inhibitors
Group 1 Serotonin and Norepinephrine Reuptake Inhibitor: Duloxetine
Summary
References
Part 3: Group 2 and Group 3 Medications
Chapter 7: Group 2 Medications: FDA-Approved Antipsychotics and Mood Stabilizers
Rationale
Antipsychotics
The Mood Stabilizer Lithium
Summary
References
Chapter 8: Group 3 Medications: Others Commonly Prescribed
Other Antidepressants
Other Antipsychotics
Other Mood Stabilizers
Anxiolytics
Sleep Aids
Future Considerations
References
Part 4: After Prescribing: Midcourse Corrections
Chapter 9: Fine Tuning Treatment
Reevaluate Therapies
Reevaluate Medication
Discontinuing Group 1 Medications
Switching Group 1 Medications
When to Consider Group 2 Antipsychotics or Lithium
When to Consider Group 3 Medications Without FDA Approval for Use in Youth
When to Consider Drug Levels or Genetic Testing
Can Genotyping Improve Medication Response?
When to Consider Consultation or a Second Opinion
References
Chapter 10: Managing Treatment Impasses
Reassess Diagnoses
Complex Psychosocial Presentations
Expert Consultation or Referral
People also search for Pediatric Psychopharmacology for Primary Care 3rd:
pediatric neurology topics
most common diagnosis in pediatric primary care
types of peds doctors
pediatric psychiatrist near me
pediatric psychopharmacology for primary care pdf